Capital Cardiovascular Consultants Research Institute (CCCRI) is committed to supporting clinical research studies that lead to measurable improvements in cardiovascular disease diagnosis, treatment, and quality of life. As part of this commitment, CCCRI employs a full-time, professional clinical research staff. These clinical research coordinators work side-by-side with our physicians to carefully monitor the safety and well-being of our research participants. Volunteering for a clinical research study is an important decision. As a volunteer you help in the development of medical therapies. These therapies may offer better treatments for life-threatening or chronic diseases. People volunteer to participate in clinical studies for a variety of reasons. Some patients volunteer for clinical research studies to take a more active role in their own healthcare, to gain access to new medical treatments before they are widely available, or to help others in the future from the information gained by their participation. Benefits of participation may include closely supervised medical care, free diagnostic services, as well as study medication and/or investigational devices at no cost to them or their insurance company. Please remember, however, participation is not always without risk. To help our patients make an informed decision about whether to participate in a clinical research study, a physician or clinical research coordinator will review with you the purpose, procedures, risks, benefits, costs, and alternatives of the study. Your participation is always voluntary. Our physicians conduct clinical research studies involving the treatment and management of coronary artery disease (blockage of coronary arteries); peripheral arterial disease (blockage in the leg or carotid arteries); acute coronary syndrome (chest pain/angina); hypertension (elevated blood pressure); and hypercholesterolemia (elevated cholesterol). We are currently enrolling patients in the following studies: MOBILITY: A Prospective, Non-Randomized, Multicenter Clinical Trial to Evaluate the Safety and Efficacy of the Absolute Pro™ Peripheral Self-Expanding Stent System in Subjects with Atherosclerotic De Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery. The Complete SE SFA Study: The Medtronic Complete Self-Expanding (SE) SFA stent for the treatment of Atherosclerotic Lesions in the Superficial Femoral Artery and/or Proximal Popliteal Artery. HCRI DAPT: A Prospective, Multi-Center, Randomized, Double-Blind Trial to Assess the Effectiveness and Safety of 12 versus 30 months of Dual Antiplatelet Therapy (DAPT) in subjects undergoing Percutaneous Coronary Intervention (PCI) with Either Drug Eluting Stent (DES) or Bare Metal Stent (BMS) Placement for the Treatment of Coronary Artery Lesions. The Trilogy ACS Study: A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome (ACS) Subjects with Unstable Angina/ Non-ST-Elevation Myocardial Infarction (UA/NSTEMI) Who are Medically Managed. EDUCATE: Endeavor Drug eluting stenting: Understanding Care, Antiplatelet agents and Thrombotic Events. PROMISE: Prospective Multi-Center Imaging Study for Evaluation of Chest Pain For more information about participating in one of our clinical research studies, please call 512-445-5998 or speak with your cardiologist at your next appointment. South Austin Thomas C. Baldacchino, MD, FACC
|